Ryuhei Okada

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Venues

Cancer science

Molecular cancer therapeutics

Cancer immunology research

Molecular imaging

National Cancer Institute

Tokyo Medical and Dental University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute Mar 05 2018

United States

Postodoctoral Fellow (Visiting) :: Molecular Imaging Program

Education History

Tokyo Medical and Dental University Apr 01 2013 - Mar 31 2017

Japan

PHD :: Clinical Anatomy

Publications

Fuyuki F Inagaki, Makoto Kano, Aki Furusawa, Takuya Kato, Ryuhei Okada, Hiroshi Fukushima, Seiichiro Takao, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment. Cancer science 115 (7) (2024)
Fuyuki F Inagaki, Makoto Kano, Aki Furusawa, Takuya Kato, Ryuhei Okada, Hiroshi Fukushima, Seiichiro Takao, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment. Cancer science 115 (7) (2024)
Fuyuki F Inagaki, Makoto Kano, Aki Furusawa, Takuya Kato, Ryuhei Okada, Hiroshi Fukushima, Seiichiro Takao, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment. Cancer science 115 (7) (2024)
Fuyuki F Inagaki, Makoto Kano, Aki Furusawa, Takuya Kato, Ryuhei Okada, Hiroshi Fukushima, Seiichiro Takao, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment. Cancer science 115 (7) (2024)
Fuyuki F Inagaki, Makoto Kano, Aki Furusawa, Takuya Kato, Ryuhei Okada, Hiroshi Fukushima, Seiichiro Takao, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment. Cancer science 115 (7) (2024)
Fuyuki F Inagaki, Makoto Kano, Aki Furusawa, Takuya Kato, Ryuhei Okada, Hiroshi Fukushima, Seiichiro Takao, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi
Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment. Cancer science (2024)
Shigeru Kondo, Ryuhei Okada, Yosuke Ariizumi, Takashi Kurita, Hiroshi Shintaku, Takahiro Asakage
A Case of Syphilis Suspected Preoperatively as a Case of Tongue Cancer. Case reports in otolaryngology 2023 (2023)
Hiroaki Wakiyama, Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy. Cancer immunology research 10 (11) (2022)
Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter C Black, Hisataka Kobayashi
Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts. Molecular cancer therapeutics (2022)
Hiroshi Fukushima, Takuya Kato, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto, Shuhei Okuyama, Eisaku Kondo, Peter L Choyke, Hisataka Kobayashi
Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancer. Cancer science 113 (9) (2022)
Takuya Kato, Ryuhei Okada, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto, Shuhei Okuyama, Hiroshi Fukushima, Peter C Black, Hisataka Kobayashi
Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models. Molecular cancer therapeutics 20 (11) (2021)
Shulian Wu, Ryuhei Okada, Yi Liu, Yuhong Fang, Feng Yan, Chen Wang, Hui Li, Hisataka Kobayashi, Yu Chen, Qinggong Tang
Quantitative analysis of vascular changes during photoimmunotherapy using speckle variance optical coherence tomography (SV-OCT). Biomedical optics express 12 (4) (2021)
Fuyuki F Inagaki, Daiki Fujimura, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Takuya Kato, Peter L Choyke, Hisataka Kobayashi
Diagnostic imaging in near-infrared photoimmunotherapy using a commercially available camera for indocyanine green. Cancer science 112 (3) (2021)
Yutaka Kurebayashi, Colleen P Olkowski, Kelly C Lane, Olga V Vasalatiy, Biying C Xu, Ryuhei Okada, Aki Furusawa, Peter C Black, Hisataka Kobayashi, Noriko Sato
Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression. Cancer research 81 (11) (2021)
Fuyuki F Inagaki, Daiki Fujimura, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Takuya Kato, Peter L Choyke, Hisataka Kobayashi
Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green. Molecular pharmaceutics 18 (3) (2021)
Adrian Rosenberg, Daiki Fujimura, Ryuhei Okada, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato, Peter L Choyke, Hisataka Kobayashi
Real-Time Fluorescence Imaging Using Indocyanine Green to Assess Therapeutic Effects of Near-Infrared Photoimmunotherapy in Tumor Model Mice. Molecular imaging 19 (2021)
Ryuhei Okada, Aki Furusawa, Fuyuki F Inagaki, Hiroaki Wakiyama, Takuya Kato, Shuhei Okuyama, Hideyuki Furumoto, Hiroshi Fukushima, Peter L Choyke, Hisataka Kobayashi
Endoscopic near-infrared photoimmunotherapy in an orthotopic head and neck cancer model. Cancer science 112 (8) (2021)
Hiroaki Wakiyama, Aki Furusawa, Ryuhei Okada, Fuyuki F Inagaki, Takuya Kato, Yasuhiro Maruoka, Peter L Choyke, Hisataka Kobayashi
Increased Immunogenicity of a Minimally Immunogenic Tumor after Cancer-Targeting Near Infrared Photoimmunotherapy. Cancers 12 (12) (2020)
Yasuhiro Maruoka, Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Daiki Fujimura, Hiroaki Wakiyama, Takuya Kato, Tadanobu Nagaya, Peter L Choyke, Hisataka Kobayashi
Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models. Cancer immunology research 8 (3) (2020)
Zeliang Zheng, Ryuhei Okada, Hisataka Kobayashi, Tadanobu Nagaya, Junxia Wei, Qi Zhou, Fred Lee, Tapan K Bera, Yun Gao, William Kuhlman, Chin-Hsien Tai, Ira H Pastan
Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity. Molecular cancer therapeutics 19 (3) (2019)

Ryuhei Okada.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ryuhei Okada